Alexion Pharmaceuticals, Inc. ALXN

Alexion Pharmaceuticals, Inc. DPO Ratio 2011-2026 | ALXN

Annual DPO Ratio Alexion Pharmaceuticals, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
78.2	68.5	72.6	56.9	90.5	89.8	92.4	44.4	108	62.8

All numbers in USD currency

Maximum	Minimum	Average
108	44.4	76.4

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Coherus BioSciences CHRS	507	$ 1.6	-3.33 %	$ 187 M	USA
Happiness Biotech Group Limited HAPP	5.06 K	-	1.35 %	$ 17.8 M	China
Celldex Therapeutics CLDX	4.06 K	$ 31.48	-0.69 %	$ 2.09 B	USA
AgeX Therapeutics AGE	5.24 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Compugen Ltd. CGEN	82.7	$ 2.68	-3.78 %	$ 250 M	Israel
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	2.52 K	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Celyad Oncology SA CYAD	55.8 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	135	-	-7.31 %	$ 87 M	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	1.79 K	-	-4.36 %	$ 27 M	USA
Anika Therapeutics ANIK	43.4	$ 14.72	-1.21 %	$ 211 M	USA
Advaxis ADXS	85.6 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	133	$ 21.3	-0.65 %	$ 2.71 B	USA
Ampio Pharmaceuticals AMPE	4.62 K	-	-11.43 %	$ 502 K	USA